Savara (SVRA) News Today $2.98 -0.21 (-6.58%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Evercore ISI Reiterates "In-Line" Rating for Savara (NASDAQ:SVRA)November 17 at 4:45 AM | americanbankingnews.comSavara (NASDAQ:SVRA) Stock Price Down 8.5% - Time to Sell?November 17 at 3:51 AM | americanbankingnews.comSavara (NASDAQ:SVRA) Hits New 1-Year Low Following Analyst DowngradeNovember 16 at 1:21 AM | americanbankingnews.comSavara (NASDAQ:SVRA) Shares Down 8.5% - Time to Sell?Savara (NASDAQ:SVRA) Trading Down 8.5% - Here's What HappenedNovember 15 at 1:37 PM | marketbeat.comPrudential Financial Inc's Strategic Acquisition of Savara Inc SharesNovember 15 at 8:01 AM | gurufocus.comHC Wainwright Brokers Increase Earnings Estimates for SavaraSavara Inc (NASDAQ:SVRA - Free Report) - Equities researchers at HC Wainwright increased their FY2024 earnings per share estimates for shares of Savara in a note issued to investors on Wednesday, November 13th. HC Wainwright analyst A. Fein now expects that the company will post earnings of ($0.4November 15 at 6:32 AM | marketbeat.comSavara (NASDAQ:SVRA) Shares Gap Down After Analyst DowngradeNovember 15 at 4:37 AM | americanbankingnews.comSavara (NASDAQ:SVRA) Sets New 12-Month Low Following Analyst DowngradeSavara (NASDAQ:SVRA) Hits New 52-Week Low After Analyst DowngradeNovember 14 at 11:05 AM | marketbeat.comEvercore ISI downgrades Savara (SVRA) to a HoldNovember 14 at 9:40 AM | markets.businessinsider.comSavara’s Promising Molbreevi Launch: Buy Rating Backed by Strategic Initiatives and IMPALA-2 Trial SuccessNovember 14 at 9:40 AM | markets.businessinsider.comEvercore Downgrades Savara on Manufacturing Concerns for Lung Disease Drug CandidateNovember 13, 2024 | finance.yahoo.comEvercore ISI Group Downgrades Savara (SVRA)November 13, 2024 | msn.comHC Wainwright Has Lowered Expectations for Savara (NASDAQ:SVRA) Stock PriceHC Wainwright decreased their price objective on shares of Savara from $10.00 to $6.00 and set a "buy" rating for the company in a report on Wednesday.November 13, 2024 | marketbeat.comSavara (NASDAQ:SVRA) Shares Gap Down on Analyst DowngradeSavara (NASDAQ:SVRA) Shares Gap Down on Analyst DowngradeNovember 13, 2024 | marketbeat.comSavara's (SVRA) In-Line Rating Reiterated at Evercore ISIEvercore ISI reaffirmed an "in-line" rating and set a $5.00 price target (down previously from $7.00) on shares of Savara in a research report on Wednesday.November 13, 2024 | marketbeat.comBest Penny stocks to buy right nowNovember 13, 2024 | fxstreet.comSavara Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 12, 2024 | finanznachrichten.deSavara Inc. to Participate in Guggenheim Inaugural Healthcare ConferenceNovember 12, 2024 | msn.comSavara Inc (NASDAQ:SVRA) Receives Average Recommendation of "Buy" from AnalystsShares of Savara Inc (NASDAQ:SVRA - Get Free Report) have received an average recommendation of "Buy" from the six ratings firms that are presently covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month price objectNovember 12, 2024 | marketbeat.comSavara (NASDAQ:SVRA) Stock Price Down 5.1% - Should You Sell?Savara (NASDAQ:SVRA) Stock Price Down 5.1% - What's Next?November 5, 2024 | marketbeat.comSavara to Present at the Guggenheim Inaugural Healthcare Innovation ConferenceNovember 4, 2024 | businesswire.comSavara Inc. Shines Spotlight on Rare Lung Disease in New TV FeatureOctober 30, 2024 | msn.comSavara Inc. Rewards New Employees with Inducement AwardsOctober 23, 2024 | msn.comSavara Announces the Rare Lung Disease, Autoimmune Pulmonary Alveolar Proteinosis (aPAP), is Highlighted on a New Episode of “The Balancing Act®” Airing on Lifetime® TVOctober 22, 2024 | businesswire.comSavara Announces New Employment Inducement GrantOctober 18, 2024 | businesswire.comSavara Inc (NASDAQ:SVRA) Receives Average Recommendation of "Buy" from BrokeragesShares of Savara Inc (NASDAQ:SVRA - Get Free Report) have been assigned a consensus recommendation of "Buy" from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 12 month price target aOctober 18, 2024 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for Savara (SVRA)October 11, 2024 | markets.businessinsider.comSavara’s Strategic Market Expansion and Diagnostic Initiatives Anchor Buy RatingOctober 9, 2024 | markets.businessinsider.comSavara (NASDAQ:SVRA) Receives Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $10.00 target price on shares of Savara in a research note on Tuesday.October 8, 2024 | marketbeat.comMarshall Wace LLP Purchases 246,107 Shares of Savara Inc (NASDAQ:SVRA)Marshall Wace LLP boosted its position in shares of Savara Inc (NASDAQ:SVRA - Free Report) by 420.0% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 304,700 shares of the company's stock after purchasing an additional 246,107 shareOctober 7, 2024 | marketbeat.comFY2025 EPS Estimates for Savara Inc (NASDAQ:SVRA) Reduced by HC WainwrightSavara Inc (NASDAQ:SVRA - Free Report) - Investment analysts at HC Wainwright cut their FY2025 EPS estimates for Savara in a report issued on Tuesday, October 1st. HC Wainwright analyst A. Fein now anticipates that the company will earn ($0.46) per share for the year, down from their previous estOctober 3, 2024 | marketbeat.comSavara's SWOT analysis: molgramostim's promise lifts rare disease stockOctober 3, 2024 | uk.investing.comSavara shares hold Outperform rating, $15 target on Molbreevi prospectsOctober 3, 2024 | uk.investing.comSavara Inc. Appoints Braden Parker as Chief Commercial OfficerOctober 2, 2024 | msn.comSavara’s Molbreevi: A $400 Million Opportunity Backed by Promising Clinical Data and Market Expansion InitiativesOctober 2, 2024 | markets.businessinsider.comEvercore ISI Remains a Buy on Savara (SVRA)October 2, 2024 | markets.businessinsider.comJMP Securities Reiterates "Market Outperform" Rating for Savara (NASDAQ:SVRA)JMP Securities reissued a "market outperform" rating and issued a $9.00 target price on shares of Savara in a report on Tuesday.October 1, 2024 | marketbeat.comNantahala Capital Management LLC Has $20.88 Million Stock Position in Savara Inc (NASDAQ:SVRA)Nantahala Capital Management LLC raised its position in Savara Inc (NASDAQ:SVRA - Free Report) by 198.2% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,180,951 shares of the company's stock after acquOctober 1, 2024 | marketbeat.comBuy Rating Affirmed for Savara on Strong Prospects for Molgramostim in aPAP TreatmentOctober 1, 2024 | markets.businessinsider.comSavara Inc. Launches Early Access Program for Rare Lung Disease TreatmentOctober 1, 2024 | msn.comSavara Inc. Grants Inducement Awards to New Chief Commercial OfficerOctober 1, 2024 | msn.comAxa S.A. Sells 279,300 Shares of Savara Inc (NASDAQ:SVRA)Axa S.A. trimmed its holdings in shares of Savara Inc (NASDAQ:SVRA - Free Report) by 21.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,051,135 shares of the company's stock after selling 279,300 shares duriSeptember 30, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Raises Stock Position in Savara Inc (NASDAQ:SVRA)Frazier Life Sciences Management L.P. grew its holdings in Savara Inc (NASDAQ:SVRA - Free Report) by 103.9% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,157,385 shares of the company's stock after buyinSeptember 29, 2024 | marketbeat.comSavara Announces New Employment Inducement GrantSeptember 27, 2024 | businesswire.comSavara Announces Expanded Access Program (EAP) for Molgramostim Inhalation Solution (Molgramostim) for Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP)September 27, 2024 | businesswire.comAffinity Asset Advisors LLC Acquires 396,850 Shares of Savara Inc (NASDAQ:SVRA)Affinity Asset Advisors LLC grew its holdings in Savara Inc (NASDAQ:SVRA - Free Report) by 34.5% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,546,850 shares of the company's stock after buying an additiSeptember 25, 2024 | marketbeat.comSavara Appoints Braden Parker as Chief Commercial Officer, Effective ImmediatelySeptember 24, 2024 | stockhouse.comFirst Light Asset Management LLC Makes New $8.07 Million Investment in Savara Inc (NASDAQ:SVRA)First Light Asset Management LLC bought a new position in shares of Savara Inc (NASDAQ:SVRA - Free Report) during the second quarter, according to its most recent filing with the SEC. The fund bought 2,002,219 shares of the company's stock, valued at approximately $8,069,000. First Light Asset ManaSeptember 24, 2024 | marketbeat.comSavara to Host Analyst and Investor Webinar on September 30, 2024September 23, 2024 | businesswire.comSavara Inc (NASDAQ:SVRA) Given Average Rating of "Buy" by BrokeragesShares of Savara Inc (NASDAQ:SVRA - Get Free Report) have been assigned an average recommendation of "Buy" from the six research firms that are covering the firm, Marketbeat reports. Six investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokeSeptember 23, 2024 | marketbeat.com Get Savara News Delivered to You Automatically Sign up to receive the latest news and ratings for SVRA and its competitors with MarketBeat's FREE daily newsletter. Email Address The Tesla Trade Is Back In Business (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. SVRA Media Mentions By Week SVRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SVRA News Sentiment▼0.370.56▲Average Medical News Sentiment SVRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SVRA Articles This Week▼263▲SVRA Articles Average Week Get Savara News Delivered to You Automatically Sign up to receive the latest news and ratings for SVRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GLSI News SYBX News BLTE News KROS News GERN News LBPH News AMPH News AKRO News NAMS News LGND News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SVRA) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Savara Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Savara With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
